Our News on Newswise

Newswise: 62af6ae79b1ef_Glimcher2022.jpg

Laurie H. Glimcher, MD named to Modern Healthcare’s 50 Most Influential Clinical Executives Class of 2022

Laurie H. Glimcher, MD, president and CEO of Dana-Farber Cancer Institute is among the 2022 class of Modern Healthcare’s 50 Most Influential Clinical Executives award. The 50 Most Influential Clinical Executives award program honors individuals in...
19-Jun-2022 2:30 PM EDT Add to Favorites

Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program

U.S. News &World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center #1 in the nation in its 2022-23 Best Children's Hospitals report. Dana-Farber/Boston Children's has been recognized as one of the top three pediatric...
15-Jun-2022 8:30 AM EDT Add to Favorites

Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier sign an oncology cooperation agreement

L’Institut Servier, Gustave Roussy (Villejuif, France), and Dana-Farber Cancer Institute (Boston, USA) have signed a cooperation agreement to foster exchange and develop bilateral collaboration among researchers from these two renowned oncology...
7-Jun-2022 12:05 PM EDT Add to Favorites

Improved Progression-Free Survival in Multiple Myeloma Patients Following Three-Drug Therapy with Autologous Stem Cell Transplant

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and...
5-Jun-2022 12:05 PM EDT Add to Favorites

Targeted Drug Achieves 43% Response Rate in KRAS-mutated Lung Cancer

Nearly 43% of patients with non-small cell lung cancer (NSCLC) whose lung cancers harbored a specific KRAS mutation responded to the experimental drug adagrasib, and the targeted agent also showed activity against lesions in the brain that...
3-Jun-2022 3:05 PM EDT Add to Favorites

Newswise: 628f70e50504d_PujaUmaretiyaGraphicASCO2022.png

Race, Ethnicity, and Poverty Linked to Worse Outcomes in Children Treated for High-Risk Neuroblastoma

Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led...
26-May-2022 5:00 PM EDT Add to Favorites

Newswise: 628fe398d6884_ASCO2022General.png

Targeted agents, combination therapies, and clinical trial equity headline Dana-Farber research at ASCO Annual Meeting

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with multiple myeloma and breast cancer. The results of these studies, along with dozens of others led by Dana-Farber researchers,...
26-May-2022 5:00 PM EDT Add to Favorites

Newswise: 628255768c64b_JenniferWilcox04.2022.jpg

Jennifer Willcox named Senior Vice President, General Counsel and Chief Governance Officer at Dana-Farber Cancer Institute

Dana-Farber Cancer Institute names new Senior Vice President, General Counsel and Chief Governance Officer
16-May-2022 10:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Yawkey Building 2.jpg

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

See All Experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Claire Monaghan
Media Relations Manager
hematology

Claire_Monaghan@dfci.harvard.edu

240-678-6494

Victoria Warren
Media Relations Manager
GI/GU

Victoria_Warren@dfci.harvard.edu

617-582-9323

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Marlena Baldacci
National Media Relations Manager

marlena_Baldacci@dfci.harvard.edu

857-215-1204

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Rob Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Twitter

close
0.44147